LIFS Stock Price, Chart, Stats & News

Life Stem Genetics Inc.
Save
Life Stem Genetics Inc. (LIFS) does not currently pay a dividend.
4,584
Market cap
–
Current P/E
–
Forward P/E
LIFS chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Life Stem Genetics Inc., an enterprise currently in its development phase, is focused on establishing a global network of clinics that specialize in stem cell therapy. Its comprehensive suite of offerings includes nutraceuticals, medical supplements, and intravenous nutritional cocktails, in addition to stem cell banking services. The company provides a variety of stem cell treatments addressing degenerative conditions, cancer, and weight management, alongside anti-aging and anti-viral therapies.
Similar securities
Based on sector and market capitalization
Report issue





